G-COSPE® tablets
Sponsors
Emzor Pharmaceutical Industries Limited
Conditions
Bioequivalence
Phase 1
Bioequivalence Study of Sulfadoxine/ Pyrimethamine Tablets in Healthy Subjects Under Fasting Conditions
NCT04577469
Start: 2020-12-31End: 2020-12-31Target: 52Updated: 2020-10-08
Bioequivalence Study of Sulfadoxine/ Pyrimethamine Dispersible Tablets in Healthy Subjects Under Fasting Conditions
NCT05497063
Start: 2022-12-31End: 2023-02-28Target: 70Updated: 2022-08-11